Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Multifaceted Intervention by the Hsp90 Inhibitor Ganetespib (STA-9090) in Cancer Cells with Activated JAK/STAT Signaling

  • David A. Proia ,

    DProia@syntapharma.com

    Affiliation Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America

  • Kevin P. Foley,

    Affiliation Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America

  • Tim Korbut,

    Affiliation Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America

  • Jim Sang,

    Affiliation Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America

  • Don Smith,

    Affiliation Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America

  • Richard C. Bates,

    Affiliation Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America

  • Yuan Liu,

    Affiliation Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America

  • Alex F. Rosenberg,

    Affiliation Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America

  • Dan Zhou,

    Affiliation Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America

  • Keizo Koya,

    Affiliation Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America

  • James Barsoum,

    Affiliation Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America

  • Ronald K. Blackman

    Affiliation Synta Pharmaceuticals Corp., Lexington, Massachusetts, United States of America

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.